Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹2,023 Cr₹1,477 Cr₹1,559 Cr₹1,191 Cr₹951 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹2,023 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹2,023 Cr
Mar2025₹1,477 Cr
Mar2024₹1,559 Cr
Mar2023₹1,191 Cr
Mar2022₹951 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹2,023 Cr
36.98
Mar2025 ₹1,477 Cr
-5.24
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹26,013.6 Cr 2.3% -5.4% 14.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

2.3%

-5.4%

14.8%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses